The antithrombotic and haemostatic effects of LASSBio-752: a synthetic, orally active compound in an arterial and venous thrombosis model in rats.
Flávia S FrattaniLidia M LimaEliezer J BarreiroRussolina Benedeta ZingaliPublished in: The Journal of pharmacy and pharmacology (2017)
Our results indicate that compound LASSBio-752 is a potential candidate for utilization in the treatment of thromboembolic diseases.